These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10339660)

  • 1. Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.
    Sumitomo K; Shimizu E; Shinohara A; Yokota J; Sone S
    Int J Oncol; 1999 Jun; 14(6):1075-80. PubMed ID: 10339660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
    Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
    Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
    J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of P16 and Rb proteins in 106 cases of lung cancer].
    Qin J; Chen G; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
    Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
    Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations.
    Ookawa K; Shiseki M; Takahashi R; Yoshida Y; Terada M; Yokota J
    Oncogene; 1993 Aug; 8(8):2175-81. PubMed ID: 8393162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines.
    Shimizu E; Zhao M; Shinohara A; Namikawa O; Ogura T; Masuda N; Takada M; Fukuoka M; Sone S
    J Cancer Res Clin Oncol; 1997; 123(10):533-8. PubMed ID: 9393586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
    Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
    Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
    Adachi J; Ookawa K; Shiseki M; Okazaki T; Tsuchida S; Morishita K; Yokota J
    Cell Growth Differ; 1996 Jul; 7(7):879-86. PubMed ID: 8809405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
    Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
    Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transferring tumor suppressor gene p16INK4A to p16INK4A-deleted cancer cells.
    Lee KY; Yoo CG; Han SK; Shim YS; Kim YW
    Korean J Intern Med; 1999 Jan; 14(1):53-8. PubMed ID: 10063314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
    Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
    Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor protein p16INK4a.
    Serrano M
    Exp Cell Res; 1997 Nov; 237(1):7-13. PubMed ID: 9417860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.